Please use this identifier to cite or link to this item: http://elar.urfu.ru/handle/10995/130300
Title: 2-Furyl-6-nitro-1,2,4-triazolo [1,5-a]pyrimidin-7-one
Authors: Fedotov, V. V.
Savateev, K. V.
Ulomsky, E. N.
Drokin, R. A.
Slepukhin, P. A.
Rusinov, V. L.
Issue Date: 2023
Publisher: MDPI
Citation: Fedotov, VV, Savateev, KV, Ulomsky, EN, Drokin, RA, Slepukhin, PA & Rusinov, VL 2023, '2-Furyl-6-nitro-1,2,4-triazolo [1,5-a]pyrimidin-7-one', Molbank, Том. 2023, № 1, M1563. https://doi.org/10.3390/M1563
Fedotov, V. V., Savateev, K. V., Ulomsky, E. N., Drokin, R. A., Slepukhin, P. A., & Rusinov, V. L. (2023). 2-Furyl-6-nitro-1,2,4-triazolo [1,5-a]pyrimidin-7-one. Molbank, 2023(1), [M1563]. https://doi.org/10.3390/M1563
Abstract: A sodium salt of 2-(fur-2-yl)-6-nitro-1,2,4-triazolo[1,5-a]pyrimidin-7-one as a close structural analogue of ZM-241385 was obtained. This heterocycle can serve as an effector for A2a adenosine receptors and possesses antiseptic activity. The structures of compounds were confirmed based on the data of 1H, 13C NMR spectroscopy, IR spectroscopy, and an elemental analysis. The structure of sodium salt 2-furyl-6-nitro-1,2,4-triazolo[1,5-a]pyrimidin-7-one was confirmed by an X-ray diffraction analysis. © 2023 by the authors.
Keywords: AZOLO[1,5-A]PYRIMIDINES
CYCLIZATION
NITROCOMPOUNDS
SEPSIS
URI: http://elar.urfu.ru/handle/10995/130300
Access: info:eu-repo/semantics/openAccess
cc-by
License text: https://creativecommons.org/licenses/by/4.0/
SCOPUS ID: 85151070818
WOS ID: 000958880600001
PURE ID: 37091855
ISSN: 1422-8599
DOI: 10.3390/M1563
Sponsorship: Ministry of Education and Science of the Russian Federation, Minobrnauka
The research funding from the Ministry of Science and Higher Education of the Russian Federation (Ural Federal University Program of Development within the Priority-2030 Program) is gratefully acknowledged.
Appears in Collections:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
2-s2.0-85151070818.pdf840,86 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons